(Q24194154)

20 October 2023

Mohammed E Madmani

1

Mohammed E

Madmani

1 reference

20 October 2023

Ahmad Yusuf Solaiman

2

Ahmad

Yusuf Solaiman

1 reference

20 October 2023

Khalil Tamr Agha

3

Khalil

Tamr Agha

1 reference

20 October 2023

Yasser Madmani

4

Yasser

Madmani

1 reference

20 October 2023

Yasser Shahrour

5

Yasser

Shahrour

1 reference

20 October 2023

Waleed Kadro

7

Waleed

Kadro

1 reference

Cochrane Database of Systematic Reviews

20 October 2023

publication date

2 June 2014

0 references

published in

0 references

cites work

Coenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in class II and III systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Oxidative stress, endothelial function and coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Supplemental ubiquinol in patients with advanced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Oxygen free radicals and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Approach to patients with heart failure and normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Lovastatin decreases coenzyme Q levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Co-enzyme Q10: a new drug for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

The epidemiology of heart failure: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Vitamin E and free radical peroxidation of lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Clinical practice. Acute pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

Coenzyme Q10 treatment in serious heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Effective and safe therapy with coenzyme Q10 for cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

An overview of contemporary etiologies of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Usefulness of coenzyme Q10 in clinical cardiology: a long-term study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Increased malondialdehyde in peripheral blood of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Oxidative stress is related to exercise intolerance in patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Evidence of oxidative stress in chronic heart failure in humans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Usefulness of taurine in chronic congestive heart failure and its prospective application

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

The effect of coenzyme Q10 in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

Coenzyme Q10 and congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008684.PUB2

7 January 2021

10.1002/14651858.CD008684.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4438828

Fatcat ID

release_yaqfryxkv5fijdiwy5pedrykye

0 references

OpenCitations bibliographic resource ID

4438828

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4438828